Page last updated: 2024-08-26

fibrinogen and Macrophage Activation Syndrome

fibrinogen has been researched along with Macrophage Activation Syndrome in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Isogai, S; Maeda, S; Naniwa, T; Ohmura, SI; Tamechika, SY; Uehara, K; Wada, J; Yamabe, T1
Assari, R; Ebadi, F; Mirmohammadsadeghi, A; Sadeghi, P; Ziaee, V1
Alkan, M; Altunok, ES; Börü, A; Demirkol, MA; Demirok, B; Gürsoy, B; Kamat, S; Satıcı, C; Sürmeli, CD1
Bracaglia, C; Caiello, I; Chatel, L; De Benedetti, F; de Min, C; Ferlin, WG; Grom, AA; Marasco, E; Pascarella, A; Prencipe, G; Strippoli, R1
Bovis, F; Cron, RQ; Davì, S; Fischbach, M; Frosch, M; Horne, A; Huber, A; Jelusic, M; Martini, A; McCurdy, DK; Minoia, F; Ravelli, A; Rigante, D; Ruperto, N; Sawhney, S; Silva, CA; Unsal, E1
Birmingham, J; Davis, AT; Hassan, NE; Kovey, K; Kruse, K; Ndika, AN; Rajasekaran, S; Zuiderveen, S1
Balbotkina, EV; Buchinskaya, NV; Chasnyk, VG; Chikova, IA; Dubko, MF; Glebova, NI; Isupova, EA; Kalashnikova, OV; Kornishina, TL; Kostik, MM; Kuchinskaya, EM; Likhacheva, TS; Masalova, VV; Snegireva, LS1

Other Studies

7 other study(ies) available for fibrinogen and Macrophage Activation Syndrome

ArticleYear
Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
    International journal of rheumatic diseases, 2022, Volume: 25, Issue:9

    Topics: Adult; C-Reactive Protein; Fibrinogen; Humans; Interleukin-18; Interleukin-6; Macrophage Activation Syndrome; Retrospective Studies; Still's Disease, Adult-Onset

2022
Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran.
    Reumatismo, 2020, Jan-28, Volume: 71, Issue:4

    Topics: Arthritis, Juvenile; Child; Child, Preschool; Female; Fibrinogen; Humans; Infant; Iran; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Mucocutaneous Lymph Node Syndrome; Platelet Count; Prospective Studies; Recurrence; Symptom Assessment

2020
Cytokine storm in severe COVID-19 pneumonia.
    Journal of medical virology, 2021, Volume: 93, Issue:9

    Topics: Aged; Alanine Transaminase; Anemia; Aspartate Aminotransferases; Biomarkers; COVID-19; Cytokine Release Syndrome; Diagnosis, Differential; Disease Progression; Female; Fibrinogen; Humans; Hyperferritinemia; Intensive Care Units; L-Lactate Dehydrogenase; Lymphohistiocytosis, Hemophagocytic; Lymphopenia; Macrophage Activation Syndrome; Male; Middle Aged; Procalcitonin; Retrospective Studies; SARS-CoV-2; Thrombocytopenia; Triglycerides; Troponin

2021
Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome.
    The Journal of allergy and clinical immunology, 2018, Volume: 141, Issue:4

    Topics: Alanine Transaminase; Animals; Antibodies, Neutralizing; Chemokine CXCL10; Chemokine CXCL9; Cytokines; Disease Models, Animal; Ferritins; Fibrinogen; Inflammation; Interferon-gamma; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Macrophage Activation Syndrome; Macrophages; Mice

2018
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Annals of the rheumatic diseases, 2019, Volume: 78, Issue:10

    Topics: Arthritis, Juvenile; Bayes Theorem; Central Nervous System; Child; Child, Preschool; Feasibility Studies; Female; Ferritins; Fibrinogen; Health Status Indicators; Humans; L-Lactate Dehydrogenase; Macrophage Activation Syndrome; Male; Platelet Count; Reference Values; ROC Curve; Sensitivity and Specificity

2019
Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2014, Volume: 15, Issue:5

    Topics: Adolescent; Anti-Inflammatory Agents; Antirheumatic Agents; C-Reactive Protein; Child; Critical Care; Female; Ferritins; Fibrinogen; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Interleukin 1 Receptor Antagonist Protein; Lymphocyte Count; Lymphocytes; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Male; Multiple Organ Failure; Neutrophils; Retrospective Studies; Sepsis; Steroids; Young Adult

2014
Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
    Seminars in arthritis and rheumatism, 2015, Volume: 44, Issue:4

    Topics: Arthritis, Juvenile; Biomarkers; Child; Child, Preschool; Diagnosis, Differential; Early Diagnosis; Female; Ferritins; Fibrinogen; Hemorrhage; Humans; Infant; L-Lactate Dehydrogenase; Leukocyte Count; Macrophage Activation Syndrome; Male; Respiratory Insufficiency; Retrospective Studies; Risk Factors; Splenomegaly

2015